{"DataElement":{"publicId":"5880869","version":"1","preferredName":"Gel Medication Skin Irritation Severity Descriptive Text","preferredDefinition":"A description of the degree of pain caused by a dermal tissue reaction from the gel treatment  drug.","longName":"GEL_SKIN_IRR_DESC","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"5880856","version":"1","preferredName":"Gel Medication Skin Irritation Severity","preferredDefinition":"A semisolid system consisting of either suspensions made up of small inorganic particles or large organic molecules interpenetrated by a liquid._A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product._A mild inflammatory dermal tissue reaction; it can be caused by physical contact with an irritant or can be a local response to a systemic trigger._Severity; used of the degree of something undesirable e.g. pain or weather.","longName":"5880693v1.0:5880854v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"5880693","version":"1","preferredName":"Gel Dosage Form Medication","preferredDefinition":"A semisolid system consisting of either suspensions made up of small inorganic particles or large organic molecules interpenetrated by a liquid.:A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","longName":"C42934:C459","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gel Dosage Form","conceptCode":"C42934","definition":"A semi-solid composed of a solid, three dimensional, cross linked matrix of polymers within a liquid, yielding a jelly-like material unable to flow at steady state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"528ED74B-00B9-03FE-E053-F662850A5FB9","latestVersionIndicator":"Yes","beginDate":"2017-06-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-06-22","modifiedBy":"ONEDATA","dateModified":"2017-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5880854","version":"1","preferredName":"Skin Irritation Severity","preferredDefinition":"A mild inflammatory dermal tissue reaction; it can be caused by physical contact with an irritant or can be a local response to a systemic trigger.:Severity; used of the degree of something undesirable e.g. pain or weather.","longName":"C50743:C25676","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Irritation","conceptCode":"C50743","definition":"A mild inflammatory dermal tissue reaction; it can be caused by physical contact with an irritant or can be a local response to a systemic trigger.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"528521AF-771E-130B-E053-F662850A25C2","latestVersionIndicator":"Yes","beginDate":"2017-06-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-06-22","modifiedBy":"ONEDATA","dateModified":"2017-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"528521AF-772F-130B-E053-F662850A25C2","latestVersionIndicator":"Yes","beginDate":"2017-06-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-06-22","modifiedBy":"ZHANGWE","dateModified":"2017-07-20","changeDescription":"6/22/17 jk created for NWU2017-09-01, Skin Toxicity SVAR tab.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181231","version":"1","preferredName":"Descriptive Text","preferredDefinition":"The text that provides a description of a topic.","longName":"DESCR_TXT","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"ALPHANUMERIC","minLength":"1","maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D3B72801-8C4C-3772-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-19","endDate":null,"createdBy":"CURTIST","dateCreated":"2004-02-19","modifiedBy":"GDEEN","dateModified":"2022-05-31","changeDescription":"3/22/22 jk added \"Qualified\" RS as part of MCL quarterly content review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5889180","version":"1","longName":"NWU2017-09-01","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"How severe?","type":"Preferred Question Text","description":"How severe?","url":null,"context":"DCP"},{"name":"DCP Text-1","type":"Alternate Question Text","description":"If yes, how severe?","url":null,"context":"DCP"},{"name":"DCP Text 2","type":"Alternate Question Text","description":"3b. If yes, how severe?","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"528EFAE3-1EEB-5279-E053-F662850AE970","latestVersionIndicator":"Yes","beginDate":"2017-06-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-06-22","modifiedBy":"LUY","dateModified":"2019-08-02","changeDescription":"6/22/17 jk created for NWU2017-09-01, Skin Toxicity SVAR tab.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}